Bruker Corporation Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 34 Fair Values set on narratives written by author
BRKR Community Narratives
BRKR: Recent Upgrade Will Drive Confidence In Core Market Resilience
Falling Funding Will Depress Revenues But Cost Cuts Help Margins
Growing Global Health R&D Investment Will Boost Diagnostic Demand
BRKR: Recent Upgrade Will Drive Confidence In Core Market Resilience
View narrativeFalling Funding Will Depress Revenues But Cost Cuts Help Margins
View narrativeGrowing Global Health R&D Investment Will Boost Diagnostic Demand
View narrativeTrending Discussion
No trending discussion available.
Recently Updated Narratives
BRKR: Premium Multiple Will Face Earnings Risk After Recent Guidance Miss
BRKR: Infection Detection Expansion Will Meet Rich Tools Sector Expectations
Growing Global Health R&D Investment Will Boost Diagnostic Demand
Snowflake Analysis
Bruker Corporation Key Details
- -0.70
- 48.48%
- -3.05%
- 75.4%
About BRKR
- Founded
- 1960
- Employees
- 11085
- CEO
- Website
View website
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.